Debate of the Decade: RCTs in the Era of Precision Oncology
How do you design clinical trials in the era of precision oncology? Are prospective randomized controlled trials necessary anymore? Drs. Ray Kurzrock, Vivek Subbiah, and Christopher Booth join Dr. Chadi Nabhan to answer these important questions.
CHRYSALIS External Control Analysis Sheds Light on Real-World Treatments, Outcomes in NSCLC
Increase in Cardiopulmonary Disease Burden Associated With Cross-Country Wildfire Smoke
Landmark Proposal: FDA Wants Big Tobacco to Lower Nicotine Levels in Cigarettes